Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001214659-25-004133·PLIANT THERAPEUTICS, INC.
Schedule 13D ownership disclosure
PLIANT THERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 729139105
Event date: 2025-03-03
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- TANG CAPITAL MANAGEMENT, LLCReported CIK 0001232621
Shares: 5,859,044.00 · Class: 9.6%
- KEVIN TANGReported CIK 0001178579
Shares: 5,859,044.00 · Class: 9.6%
- TANG CAPITAL PARTNERS, LPReported CIK 0001191935
Shares: 3,295,127.00 · Class: 5.4%
- TANG CAPITAL PARTNERS INTERNATIONAL, LP
Shares: 2,563,917.00 · Class: 4.2%
- TANG CAPITAL PARTNERS III, INCReported CIK 0002036763
Shares: 0.00 · Class: 0%
- TANG CAPITAL PARTNERS IV, INCReported CIK 0002036770
Shares: 0.00 · Class: 0%
- CONCENTRA BIOSCIENCES, LLCReported CIK 0001970065
Shares: 0.00 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-25-004133
- Form type
- SCHEDULE 13D
- Filer
- PLIANT THERAPEUTICS, INC.
- CIK
- CIK 1746473
- Filed
- Mar 10, 2025
- Reporting period
- Mar 03, 2025
- Description
- Schedule 13D beneficial ownership